Michael Shaw

Scientific Director, Head of IO Innovation Lab at Takeda Pharmaceuticals (formerly Nycomed) - Lexington, MA, US

Michael Shaw's Colleagues at Takeda Pharmaceuticals (formerly Nycomed)
Yoko Momonoi

Executive Director, Global Regulatory CMC Cell and Gene Therapy

Contact Yoko Momonoi

Raghu Shivappa

Vice President, Head of Global Biologics and Gene Therapy Process Development

Contact Raghu Shivappa

Suzanne Collins

Sr. Director, Analytics, Insights & Communications

Contact Suzanne Collins

Stephanie Hunter-Banks

Senior Director, US Medical Excellence Learning and Development

Contact Stephanie Hunter-Banks

William Lichtman

Director, Product Operations Lead, Biologics

Contact William Lichtman

Amina Lobban

Director, Head of HR Business Excellence, Global Manufacturing, Supply & Quality (GMS/GQ)

Contact Amina Lobban

Jean Ciano

Head, R&D Capability Development

Contact Jean Ciano

View All Michael Shaw's Colleagues
Michael Shaw's Contact Details
HQ
224-554-6500
Location
316 Huntington Avenue,Boston,Massachusetts,02115,United States
Company
Takeda Pharmaceuticals (formerly Nycomed)
Michael Shaw's Company Details
Takeda Pharmaceuticals (formerly Nycomed) logo, Takeda Pharmaceuticals (formerly Nycomed) contact details

Takeda Pharmaceuticals (formerly Nycomed)

Lexington, MA, US • >10000 Employees
Major Drugs

On October 1, 2011, Takeda Pharmaceutical Company Limited acquired Nycomed. Through the acquisition, Takeda, the largest pharma company in Asia, broadened its coverage of the global pharmaceutical market, especialy in Europe and emergig markets. More information on http://www.takeda.com. The below information is from before the acquisition: Nycomed is a privately owned global pharmaceutical company with a diversified portfolio focused on branded medicines in gastroenterology, respiratory and inflammatory diseases, pain, osteoporosis and tissue management. A range of OTC products completes the portfolio. Its R&D is structured around collaborations. In-licensing and expanding in emerging markets are cornerstones of the company's growth strategy. Nycomed employs 12,500 associates worldwide, and its products are sold in more than 100 countries. It has strong platforms in Europe and in fast-growing markets such as Russia/CIS, Latin America, Asia and the Middle East. In the US and Japan its products are available through best in class partners. Headquartered in Zurich, Switzerland, the company generated total sales of € 3.2 billion in 2010 and an adjusted EBITDA of € 851 million.

Branded Pharmaceuticals Gastroenterology Respiratory Conditions Inflammatory Diseases Pain Management Osteoporosis Treatment Over The Counter
Details about Takeda Pharmaceuticals (formerly Nycomed)
Frequently Asked Questions about Michael Shaw
Michael Shaw currently works for Takeda Pharmaceuticals (formerly Nycomed).
Michael Shaw's role at Takeda Pharmaceuticals (formerly Nycomed) is Scientific Director, Head of IO Innovation Lab.
Michael Shaw's email address is ***@takeda.com. To view Michael Shaw's full email address, please signup to ConnectPlex.
Michael Shaw works in the Major Drugs industry.
Michael Shaw's colleagues at Takeda Pharmaceuticals (formerly Nycomed) are Yoko Momonoi, Raghu Shivappa, Suzanne Collins, Stephanie Hunter-Banks, William Lichtman, Amina Lobban, Jean Ciano and others.
Michael Shaw's phone number is 224-554-6500
See more information about Michael Shaw